Announcements Trials

Browse Landscape

Phase

Status

Completed 12 Recruiting 6 Active not recruiting 5 Terminated 4 Unknown 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Small Cell Lung Carcinoma 1 Neoplasms 1

Interventions

Specimen Handling 3 Blood Specimen Collection 2 somapacitan 1 pembrolizumab 1 ibrutinib 1 gallium 68 PSMA-11 1 fluorodopa F 18 1 exemestane 1 durvalumab 1 Tumor Burden 1 Telemedicine 1 Tamoxifen 1 Standard of Care 1 Semen Analysis 1 Radiography, Panoramic 1 Protons 1 Physical Examination 1 Photons 1 Music Therapy 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 JNJ-64619178 1 JNJ-64264681 1 High-Intensity Interval Training 1 Exercise 1 Esophagectomy 1 Electrocardiography 1 Community Health Workers 1 Angptl4 protein, mouse 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Neoplasms × durvalumab × Clear all

NCT05303532 2026-05-19

ROSY-D

AstraZeneca

Phase 3 Enrolling by invitation

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡